Carlsbad, CA, United States of America

Alain Philippe Vasserot

Average Co-Inventor Count = 7.3

ph-index = 15

Forward Citations = 896(Granted Patents)

Forward Citations (Not Self Cited) = 763(Sep 21, 2024)

DiyaCoin DiyaCoin 0.94 

Inventors with similar research interests:


Location History:

  • Saratoga, CA (US) (1999 - 2001)
  • Berkeley, CA (US) (2003 - 2006)
  • Calabasas, CA (US) (2018)
  • Carlsbad, CA (US) (2004 - 2024)


Years Active: 1999-2025

where 'Filed Patents' based on already Granted Patents

98 patents (USPTO):
22 patents (CIPO):

Title: Alain Philippe Vasserot: Innovator Extraordinaire in Biomedical Science

Introduction:

Alain Philippe Vasserot, a renowned inventor and researcher hailing from Carlsbad, California, has made significant contributions to the field of biomedical science. With an impressive portfolio of 93 patents, Vasserot's groundbreaking discoveries have revolutionized the treatment of various medical conditions. This article explores his latest patents, career highlights, notable collaborations, and the impact of his work on the field of healthcare.

Latest Patents:

Vasserot's recent patents highlight his relentless pursuit of finding innovative solutions for challenging medical conditions. Among his noteworthy advances are two patents: "Methods of Suppressing Rheumatoid Arthritis using an Anti-IL-6 Antibody" and "Innovative Discovery of Protein Fragments of Cysteinyl-tRNA Synthetase." These patents focus on developing effective treatments for rheumatoid arthritis and diagnostic compositions related to protein fragments of Cysteinyl-tRNA synthetase, respectively. Such groundbreaking inventions often pave the way for improved patient outcomes and revolutionize the healthcare landscape.

Career Highlights:

With his extensive expertise, Vasserot has made significant contributions to the pharmaceutical industry. Some of the milestones in his career include his tenure at Atyr Pharma, Inc. and Pangu Biopharma Limited. At Atyr Pharma, Inc., Vasserot played a crucial role in pioneering novel therapies and actively contributed to the development of innovative drug discoveries. His involvement at Pangu Biopharma Limited showcased his dedication to unraveling the mysteries of protein fragments, focusing on diagnostic and therapeutic applications that have immense potential for improved patient care.

Collaborations:

Throughout his illustrious career, Vasserot has had the opportunity to collaborate with exceptional professionals in the field. Notably, he has worked alongside esteemed individuals such as Jeffry Dean Watkins and Leslie Ann Greene. These collaborations have allowed Vasserot to leverage varied perspectives and expertise, ultimately leading to groundbreaking advancements in biomedical science. The collaborative efforts between Vasserot and his colleagues have further fostered innovation and pushed the boundaries of medical knowledge.

Conclusion:

Alain Philippe Vasserot's contributions to the field of biomedical science are nothing short of remarkable. With an impressive patent portfolio consisting of 93 registered inventions, Vasserot has significantly impacted the treatment landscape for various medical conditions. His latest patents, focusing on rheumatoid arthritis and protein fragments for diagnostic purposes, demonstrate his continuous passion for pushing the boundaries of scientific knowledge. Through his extensive career and noteworthy collaborations, Vasserot has cemented his position as an innovator extraordinaire, transforming healthcare with his life-changing inventions.

Disclaimer: The information provided in this article is based on available data and research. Any inaccuracies or omissions are unintentional. The aim is to provide a general overview of Alain Philippe Vasserot's work and not to offer exhaustive details. For precise and up-to-date information, it is recommended to refer to official sources and publications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…